Therefore we last asked whether this modified form would still be an eligible target for anti-neoplasic treatments that prove toxic for cancer cells because they trigger Bcl-2/Bcl-xLphosphorylation and hence abrogate their anti-apoptotic activity. This evidence concerns the gene BCL2 and cancer.